COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle has won a seat on the Defense Health Agency’s (DHA) Omnibus IV contract, a 10-year, $10 billion multiple award contract vehicle for acquiring professional and technical solutions supporting military medical research and development programs.
The Department of Defense (DoD) has ongoing needs for discovery and integration of medical solutions to enhance force readiness, resilience, and rehabilitation. The OMNI IV was established to support related medical research and development for the DoD. Battelle was selected as a prime contractor in all OMNI IV market segments that includes:
- Research & Development (R&D)
- R&D Support Services
- Regulatory Processes
- Translational Science Support and Services
“As a trusted health solution provider, Battelle provides cross-disciplinary scientific and engineering expertise to improve public health and advance medical discoveries,” said Nicole Brennan, Division Manager of Health Research at Battelle. “We’re looking forward to working with our team to provide the most innovative solutions to the DoD that will improve health outcomes.”
About Battelle
Every day, the people of Battelle apply science and technology to solving what matters most. At major technology centers and national laboratories around the world, Battelle conducts research and development, designs and manufactures products, and delivers critical services for government and commercial customers. Headquartered in Columbus, Ohio since its founding in 1929, Battelle serves the national security, health and life sciences, and energy and environmental industries. For more information, visit www.battelle.org.
